CSC Wins $19.7 Million Award for Advanced Development of Biodefense Vaccines

Article

EL SEGUNDO, Calif. -- Computer Sciences Corporation (CSC) announced that DVC LLC, a CSC company, has been awarded approximately $19.7 million in grants and contract modifications from the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health.

The new grants and contract modifications are in addition to the award of an $11 million grant to CSC from the NIAID in September 2003.

Under the terms of these new awards, DVC will continue the advanced development of vaccines for tularemia, botulism and Venezuelan equine encephalitis.  The company will perform stability testing and manufacture a current good manufacturing practices pilot batch of live tularemia vaccine.  DVC also will conduct a phase 2 clinical trial for its Venezuelan equine encephalitis vaccine candidate and continue development of a stable multivalent botulinum vaccine candidate.

NIAID is a component of the National Institutes of Health, an agency of the U.S. Department of Health and Human Services.  NIAID conducts and supports research that strives to understand, treat and ultimately prevent the myriad of infectious, immunologic and allergic diseases that threaten hundreds of millions of people worldwide.

DVC is a biopharmaceutical company dedicated to the development and licensure of safe and efficacious biodefense vaccines and therapeutics.  DVC is part of CSCs Enforcement, Security and Intelligence organization, which CSC created in 2002 to support programs enhancing U.S. security.

Source: Computer Sciences Corporation

Recent Videos
Pathogen Playbook Presenter: Sharon Ward-Fore, BS, MS, MT(ASCP), CIC, FAPIC
Mark Wiencek, PhD
Rebecca Crapanzano-Sigafoos, DrPH, CIC, AL-CIP, FAPIC
The CDC’s updated hospital respiratory reporting requirement has added new layers of responsibility for infection preventionists. Karen Jones, MPH, RN, CIC, FAPIC, clinical program manager at Wolters Kluwer, breaks down what it means and how IPs can adapt.
Studying for the CIC using a digital tablet and computer (Adobe Stock 335828989 by NIKCOA)
Infection Control Today's Conversations with the HSPA President, Arlene Bush, CRCST, CER, CIS, SME, DSMD, CRMST
Infection Control Today's Conversations with the HSPA President, Arlene Bush, CRCST, CER, CIS, SME, DSMD, CRMST
Cheron Rojo, BS, FCS, CHL,  CER, CFER, CRCST
Matthias Tschoerner, Dr Sc
Standardizing Cleaning and Disinfection
Related Content